why choose us

First received: February 15, 2023

Clinical Trial: Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Non-cystic Fibrosis Bronchiectasis

Study Type: INTERVENTIONAL


Official Title: Evaluating Trikafta for the Treatment of Patients With Non-cystic Fibrosis Bronchiectasis (NCFBE)

Brief Summary: Study participants with non-cystic fibrosis bronchiectasis will be given Trikafta for four weeks.The researchers will monitor clinical endpoints, quality of life, and weight.Additionally, cutaneous punch biopsy material will be collected from each participant to test cellular response to Trikafta.

Read more